NUTX vs UHS
NUTX: Nutex Health is a healthcare services company operating a network of micro-hospitals and providing population health management solutions. UHS: A diversified operator of a massive network of inpatient behavioral health centers and acute care hospitals across the US and UK.
Side-by-side fundamentals
| Metric | NUTX | UHS | Edge |
|---|---|---|---|
| Price as of 2026-10-08 close | $205.01 | $175.72 | |
| Market cap | $1.4B | $10.4B | |
| P/E as of 2026-10-08 | 15.81 | 7.16 | UHS lower |
| PEG as of 2026-10-08, 3-year EPS CAGR to FY2025 | n/a | 0.20 | |
| Net margin FY2025, SEC XBRL | +8.1% | +8.6% | UHS higher |
| Gross margin FY2025, SEC XBRL | +50.8% | n/a | |
| Operating margin FY2025, SEC XBRL | +31.5% | +11.5% | NUTX higher |
| ROE FY2025, SEC XBRL | +16.7% | +20.3% | UHS higher |
| ROA FY2025, SEC XBRL | +7.7% | +9.6% | UHS higher |
| Debt / equity as of 2026-09-03 | 0.92 | 0.65 | UHS lower |
| Revenue growth (YoY) as of 2026-09-03 | +41.0% | +10.1% | NUTX higher |
| Revenue CAGR (3y) SEC XBRL | +58.6% | +9.0% | NUTX higher |
| Dividend yield as of 2026-09-03 | +6.3% | +0.5% | NUTX higher |
| Dividend streak (yrs) SEC XBRL | n/a | 5 | |
| Beta as of 2026-09-03 | 1.61 | 0.49 | |
| 1-year return as of 2026-10-08 close | +99.5% | -14.4% | NUTX higher |
Fundamentals: SEC XBRL company filings for the figures marked with a fiscal year, and market data, as of 2026-09-03 for the rest. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-10-08.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.